Search
for

    Sort by

    Research 991–1000 of 1000+

    1. Internal peacekeepers and external mediators: A new model of peripheral immune tolerance involving regulatory T cells and mesenchymal stem cells Advances in Clinical and Experimental Medicine · 2026
    2. MicroRNA-Enriched Exosomes from Different Sources of Mesenchymal Stem Cells Can Differentially Modulate Functions of Immune Cells and Neurogenesis Biomedicines · 2021 · 29 citations
    3. Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata Journal of Dermatological Science · 2024 · 1 citations
    4. 64750 Which lessons on the role of TNF-a in hair follicle (patho-)biology can be learned from TNF-a inhibitor-induced alopecia areata? Journal of the American Academy of Dermatology · 2025
    5. Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata British Journal of Dermatology · 2024 · 23 citations
    6. 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo Journal of Investigative Dermatology · 2025
    7. Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy JAAD Case Reports · 2024 · 2 citations
    8. Alopecia Areata: Clinical Treatment 2019 · 2 citations
    9. 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata Journal of Investigative Dermatology · 2018 · 1 citations
    10. 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials 2017